Rythmol - Used for: Treating certain types of life-threatening irregular heartbeat (ventricular arrhythmias). It is also used to help maintain a normal heart rhythm in certain patients who have certain types of irregular heartbeat (paroxysmal atrial fibrillation/flutter [PAF], paroxysmal supraventricular tachycardia [PSVT]).
Rythmol is a class 1C antiarrhythmic medicine. It works in the heart to stabilize its action and regulate heartbeat.
Rythmol is in a group of drugs called Class IC anti-arrhythmics. It affects the way your heart beats.
Rythmol is used in certain situations to prevent serious heart rhythm disorders.
Rythmol may also be used for purposes not listed in this medication guide.
Rythmol is a Class 1C antiarrhythmic drug with local anesthetic effects, and a direct stabilizing action on myocardial membranes. It is used in the treatment of atrial and ventricular arrhythmias. It works by slowing the influx of sodium ions into the cardiac muscle cells, causing a decrease in excitablity of the cells. Rythmol has local anesthetic activity approximately equal to procaine.
Indication: Used to prolong the time to recurrence of paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms in patients without structural heart disease. Also used for the treatment of life-threatening documented ventricular arrhythmias, such as sustained ventricular tachycardia.
Prolonged time to recurrence of paroxysmal atrial fibrillation/flutter or paroxysmal supraventricular tachycardia associated with disabling symptoms in patients without structural heart disease; treatment of ventricular arrhythmias (eg, sustained ventricular tachycardia [VT]) that are life-threatening. ERProlong the time to recurrence of symptomatic atrial fibrillation in patients with structural heart disease.
In patients without structural heart disease, Rythmol (Rythmol HCl) is indicated to prolong the time to recurrence of paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms. paroxysmal supraventricular tachycardia (PSVT) associated with disabling symptoms. As with other agents, some patients with atrial flutter treated with Rythmol have developed 1:1 conduction, producing an increase in ventricular rate. Concomitant treatment with drugs that increase the functional AV refractory period is recommended. The use of Rythmol HCl in patients with chronic atrial fibrillation has not been evaluated. Rythmol HCl should not be used to control ventricular rate during atrial fibrillation. Rythmol HCl is also indicated for the treatment of documented ventricular arrhythmias, such as sustained
Rythmol is used to prevent irregular heartbeats such as atrial fibrillation (AF) from occurring again in patients who do not have structural heart disease.
Rythmol belongs to the group of medicines known as antiarrhythmics. It works directly on the heart tissue and will slow the nerve impulses in the heart. This helps keep the heart rhythm normal.
There is a chance that Rythmol may cause new or make worse existing heart rhythm problems when it is used. Since it has been shown to cause severe problems in some patients, Rythmol is only used to treat serious heart rhythm problems. Discuss this possible effect with your doctor.
This medicine is available only with your doctor's prescription.